Myelin: structure, function, development, and clinical significance

Composition and microscopic structure

Myelin is composed primarily of lipids with a significant protein component. Typical descriptions indicate a majority lipid fraction with the remainder proteins, creating a compacted membrane whose thickness varies with axon size. The sheath is not continuous: regular interruptions called nodes of Ranvier expose short axon segments and are essential for rapid conduction. In the central nervous system oligodendrocytes extend processes that wrap multiple axons, while in the peripheral nervous system individual Schwann cells form myelin around single axon segments.

Functions and mechanisms

The principal role of myelin is to increase the speed and efficiency of electrical signaling. By insulating the axon and concentrating ion channels at the nodes of Ranvier, myelin enables saltatory conduction, where action potentials jump between nodes rather than travel along every membrane patch. This arrangement reduces metabolic cost and supports high‑speed communication across long distances in the nervous system.

Development and maintenance

Myelination is an extended developmental process that begins in fetal life and continues through infancy, childhood and adolescence for many brain regions. The timing and pattern of myelination influence cognitive and motor maturation. Myelin is maintained by specialized glial cells and requires ongoing metabolic support; when maintenance fails, myelin can thin or break down. Cells that can replace or repair myelin—oligodendrocyte precursor cells in the CNS and Schwann cells in the PNS—play a central role in recovery after injury, although repair capacity is variable.

Clinical importance and disorders

Damage or loss of myelin—demyelination—impairs neural transmission and underlies a range of neurological conditions. Prominent examples include autoimmune disorders such as multiple sclerosis, which primarily affects CNS myelin, and peripheral neuropathies in which Schwann cell function is disrupted. Demyelination has been discussed in connection with age-related cognitive decline and neurodegenerative processes; its relationship to diseases like Alzheimer's disease is an active area of research rather than a settled cause-and-effect claim.

• Common clinical features: slowed conduction, sensory disturbances, weakness, and conduction block.
• Diagnostic tools: clinical examination, electrophysiology and magnetic resonance imaging that highlights white‑matter changes.
• Repair approaches: immunomodulation, symptomatic therapies, and experimental strategies aimed at promoting remyelination.

Notable facts and distinctions

Myelin differs between CNS and PNS in cellular origin and regenerative capacity. Its biochemical makeup emphasizes lipids such as cholesterol and sphingolipids alongside specific myelin proteins, reflecting a balance of membrane fluidity and compactness (lipids, proteins). The integrity of myelin is essential for normal neural function and for the timing of complex behaviors and reflexes. Active research explores how myelination patterns change with experience, learning and aging, and how interventions might enhance remyelination after disease or injury.

For further reading and basic references, consult accessible neuroscience resources and clinical summaries that describe myelin biology, its imaging in medical practice, and ongoing therapeutic developments (brain, CNS, MS).